Torrent Pharma inks agreement with Boehringer Ingelheim to acquire 3 anti-diabetes brands
The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market
The acquisition further strengthens Torrent’s existing diabetes care portfolio and its presence in the Oral Anti Diabetic market
Granules has undertaken a proactive, voluntary and comprehensive remediation plan to address the six form 483 observations raised by the USFDA
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
The celebrations began with the unveiling of the Biocon Anthem
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Subscribe To Our Newsletter & Stay Updated